SCHEMBL2227630

SCHEMBL2227630

O=C(OCc1cncs1)N1CCC(CCOc2ccc(-c3ccccc3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TEAD1 P28347 1/20 0.47
TEAD3 Q99594 1/20 0.47
FAAH O00519 1/20 0.47
GRIN2B Q13224 11/20 0.43
CYP2D6 P10635 4/20 0.42
CYP2C9 P11712 4/20 0.42
CYP3A4 P08684 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
CHEK2 O96017 1/20 0.41
RAB9A P51151 1/20 0.41
CHRM4 P08173 1/20 0.41
PARP15 Q460N3 1/20 0.40
PARP10 Q53GL7 1/20 0.40
KCNH2 Q12809 1/20 0.40
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2226276 0.94 TEAD1 (0.53) TEAD1TEAD3FAAHGRIN2BCYP2D6
SCHEMBL2228411 0.93 TEAD1 (0.49) TEAD1TEAD3FAAHGRIN2BCYP2D6
SCHEMBL2228392 0.92 TEAD1 (0.45) TEAD1TEAD3FAAHGRIN2BCYP2D6
SCHEMBL2365329 0.92 FAAH (0.50) TEAD1TEAD3FAAHGRIN2BCYP2D6
SCHEMBL2226508 0.91 FAAH (0.47) TEAD1TEAD3FAAHGRIN2BCYP2D6
SCHEMBL2229515 0.90 HRH2 (0.47) TEAD1TEAD3GRIN2BCHEK2PARP15
SCHEMBL2285777 0.89 TEAD1 (0.44) TEAD1TEAD3FAAHGRIN2BCYP2D6
SCHEMBL2227775 0.89 LMNA (0.47) TEAD1TEAD3FAAHGRIN2BCYP3A4
SCHEMBL2227860 0.89 GRIN2B (0.47) TEAD1TEAD3FAAHGRIN2BCYP3A4
SCHEMBL2227973 0.88 TEAD1 (0.41) TEAD1TEAD3FAAHGRIN2BCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 US claimed
EP-2526100-B1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI SA (FR) 2013-12-04 EP claimed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 US claimed
WO-2011089550-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2011-07-28 WO claimed
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 US disclosed
EP-2526100-B1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI SA (FR) 2013-12-04 EP disclosed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 US disclosed
WO-2011089550-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2011-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION PRMT9, PRMT8, CBR1 TEAD1 4192/4885TEAD3 3201/4885FAAH 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.